These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

198 related articles for article (PubMed ID: 30266945)

  • 1. DICER1 mutations are frequent in müllerian adenosarcomas and are independent of rhabdomyosarcomatous differentiation.
    Bean GR; Anderson J; Sangoi AR; Krings G; Garg K
    Mod Pathol; 2019 Feb; 32(2):280-289. PubMed ID: 30266945
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mullerian adenosarcoma: clinicopathologic and molecular characterization highlighting recurrent BAP1 loss and distinctive features of high-grade tumors.
    Momeni Boroujeni A; Kertowidjojo E; Wu X; Soslow RA; Chiang S; Da Silva EM; Weigelt B; Chui MH
    Mod Pathol; 2022 Nov; 35(11):1684-1694. PubMed ID: 36138078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. High-grade Müllerian Adenosarcoma: Genomic and Clinicopathologic Characterization of a Distinct Neoplasm With Prevalent TP53 Pathway Alterations and Aggressive Behavior.
    Hodgson A; Amemiya Y; Seth A; Djordjevic B; Parra-Herran C
    Am J Surg Pathol; 2017 Nov; 41(11):1513-1522. PubMed ID: 28834809
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Significantly greater prevalence of DICER1 alterations in uterine embryonal rhabdomyosarcoma compared to adenosarcoma.
    de Kock L; Yoon JY; Apellaniz-Ruiz M; Pelletier D; McCluggage WG; Stewart CJR; Dickson BC; Rouzbahman M; Clarke BA; Foulkes WD
    Mod Pathol; 2020 Jun; 33(6):1207-1219. PubMed ID: 31900434
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinicopathological analysis of 22 Müllerian adenosarcomas and the sequencing of DICER1 mutation.
    Yao X; Wang W; He Y
    Diagn Pathol; 2024 Apr; 19(1):56. PubMed ID: 38570882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Endometrial Stem/Progenitor cell (ES/PC) Marker Expression Profile in Adenosarcoma and Endometrial Stromal Sarcoma.
    Yoon JY; de Kock L; Stewart CJR; McCluggage WG; Foulkes WD; Clarke BA; Rouzbahman M
    Cancer Treat Res Commun; 2021; 27():100363. PubMed ID: 33838572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A survey of DICER1 hotspot mutations in ovarian and testicular sex cord-stromal tumors.
    Conlon N; Schultheis AM; Piscuoglio S; Silva A; Guerra E; Tornos C; Reuter VE; Soslow RA; Young RH; Oliva E; Weigelt B
    Mod Pathol; 2015 Dec; 28(12):1603-12. PubMed ID: 26428316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DICER1-associated embryonal rhabdomyosarcoma and adenosarcoma of the gynecologic tract: Pathology, molecular genetics, and indications for molecular testing.
    Apellaniz-Ruiz M; McCluggage WG; Foulkes WD
    Genes Chromosomes Cancer; 2021 Mar; 60(3):217-233. PubMed ID: 33135284
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Embryonal rhabdomyosarcoma of the uterine corpus: a clinicopathological and molecular analysis of 21 cases highlighting a frequent association with DICER1 mutations.
    Bennett JA; Ordulu Z; Young RH; Pinto A; Van de Vijver K; Burandt E; Wanjari P; Shah R; de Kock L; Foulkes WD; McCluggage WG; Ritterhouse LL; Oliva E
    Mod Pathol; 2021 Sep; 34(9):1750-1762. PubMed ID: 34017064
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DICER1 hotspot mutations in ovarian Sertoli-Leydig cell tumors: a potential association with androgenic effects.
    Kato N; Kusumi T; Kamataki A; Tsunoda R; Fukase M; Kurose A
    Hum Pathol; 2017 Jan; 59():41-47. PubMed ID: 27664536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Uterine adenosarcomas are mesenchymal neoplasms.
    Piscuoglio S; Burke KA; Ng CK; Papanastasiou AD; Geyer FC; Macedo GS; Martelotto LG; de Bruijn I; De Filippo MR; Schultheis AM; Ioris RA; Levine DA; Soslow RA; Rubin BP; Reis-Filho JS; Weigelt B
    J Pathol; 2016 Feb; 238(3):381-8. PubMed ID: 26592504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genomewide copy number analysis of Müllerian adenosarcoma identified chromosomal instability in the aggressive subgroup.
    Lee JC; Lu TP; Changou CA; Liang CW; Huang HN; Lauria A; Huang HY; Lin CY; Chiang YC; Davidson B; Lin MC; Kuo KT
    Mod Pathol; 2016 Sep; 29(9):1070-82. PubMed ID: 27255164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DICER1 and FOXL2 Mutation Status Correlates With Clinicopathologic Features in Ovarian Sertoli-Leydig Cell Tumors.
    Karnezis AN; Wang Y; Keul J; Tessier-Cloutier B; Magrill J; Kommoss S; Senz J; Yang W; Proctor L; Schmidt D; Clement PB; Gilks CB; Huntsman DG; Kommoss F
    Am J Surg Pathol; 2019 May; 43(5):628-638. PubMed ID: 30986800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mixed Endometrioid Adenocarcinoma and Müllerian Adenosarcoma of the Uterus and Ovary: Clinicopathologic Characterization With Emphasis on its Distinction From Carcinosarcoma.
    El Hallani S; Arora R; Lin DI; Måsbäc A; Mateoiu C; McCluggage WG; Nucci MR; Otis CN; Parkash V; Parra-Herran C; Longacre TA
    Am J Surg Pathol; 2021 Mar; 45(3):374-383. PubMed ID: 33565764
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gynecologic Cancer InterGroup (GCIG) consensus review for mullerian adenosarcoma of the female genital tract.
    Friedlander ML; Covens A; Glasspool RM; Hilpert F; Kristensen G; Kwon S; Selle F; Small W; Witteveen E; Russell P
    Int J Gynecol Cancer; 2014 Nov; 24(9 Suppl 3):S78-82. PubMed ID: 25341585
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pediatric Sertoli-Leydig Cell Tumors of the Ovary: An Integrated Study of Clinicopathological Features, Pan-cancer-Targeted Next-generation Sequencing and Chromosomal Microarray Analysis From a Single Institution.
    Yang B; Chour W; Salazar CG; Zamiara P; Schmidt RJ; Raca G; Shillingford N; Zhou S; Warren M; Parham DM; Pawel B; Wang LL
    Am J Surg Pathol; 2024 Feb; 48(2):194-203. PubMed ID: 37946548
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Uterine adenosarcoma with rhabdomyosarcomatous overgrowth. Brief communication.
    Yilmaz F; Ozdemir N; Akalin T; Veral A; Dikmen Y; Erhan Y
    Eur J Gynaecol Oncol; 2000; 21(4):430-2. PubMed ID: 11055503
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Uterine adenosarcoma: Clinical significance of histological classification and SNP array analysis.
    Ngo C; Cotteret S; Deneche I; Kfoury M; Chehab R; Tran-Dien A; Vibert J; Leary A; Gouy S; Maulard A; Morice P; Scoazec JY; Pautier P; Genestie C
    Hum Pathol; 2024 Jun; 148():14-22. PubMed ID: 38688412
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers.
    Heravi-Moussavi A; Anglesio MS; Cheng SW; Senz J; Yang W; Prentice L; Fejes AP; Chow C; Tone A; Kalloger SE; Hamel N; Roth A; Ha G; Wan AN; Maines-Bandiera S; Salamanca C; Pasini B; Clarke BA; Lee AF; Lee CH; Zhao C; Young RH; Aparicio SA; Sorensen PH; Woo MM; Boyd N; Jones SJ; Hirst M; Marra MA; Gilks B; Shah SP; Foulkes WD; Morin GB; Huntsman DG
    N Engl J Med; 2012 Jan; 366(3):234-42. PubMed ID: 22187960
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anaplastic sarcomas of the kidney are characterized by DICER1 mutations.
    Wu MK; Vujanic GM; Fahiminiya S; Watanabe N; Thorner PS; O'Sullivan MJ; Fabian MR; Foulkes WD
    Mod Pathol; 2018 Jan; 31(1):169-178. PubMed ID: 28862265
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.